THE ACTIONS OF GR32191B, A THROMBOXANE RECEPTOR ANTAGONIST, ON THE EFFECTS OF INHALED PAF ON HUMAN AIRWAYS

被引:18
作者
STENTON, SC
WARD, C
DUDDRIDGE, M
HARRIS, A
PALMER, JBD
HENDRICK, DJ
WALTERS, EH
机构
[1] UNIV NEWCASTLE UPON TYNE,NEWCASTLE GEN HOSP,CHEST UNIT,NEWCASTLE TYNE,ENGLAND
[2] GLAXO GRP RES LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND
关键词
D O I
10.1111/j.1365-2222.1990.tb02689.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We investigated acute bronchoconstriction and changes in airway responsiveness to methacholine following the inhalation of platelet activating factor (PAF) in an open study of 12 non‐asthmatic subjects. Ventilatory function was monitored using a flow rate at 30% of vital capacity (V̇30) and airway responsiveness was measured as PD40V̇30, i.e. the dose of metacholine causing a 40% fall in V̇30. PAF (3–422 μg) resulted in dose‐related acute bronchoconstriction in 10 of the 12 subjects. There was no association between the airway responsiveness to PAF and to methacholine. Ten subjects showed some increase in airway responsiveness to methacholine 1 or 3 days following PAF. Overall, these changes were statistically significant (P < 0·05) but were of small magnitude (geometric mean PD40V̇30 pre‐PAF=457 μg; 24 hr after PAF = 259 μg; 72 hr after PAF =258 μg) and variable: only seven subjects showing increased airway responsiveness on both day 1 and day 3 after PAF. Six subjects who appeared to show increases in airway responsiveness following PAF were re‐studied with the inhaled PAF pre‐medicated by either placebo or a specific thromboxane receptor antagonist (GR32191B) in a double‐blind fashion. GR32191B did not reduce the acute bronchoconstriction due to PAF. In this part of the study, these six subjects did not show significant increases in airway responsiveness following the placebo pre‐medicated PAF challenge and so no effect of the drug on airway responsiveness could be shown. We conclude that PAF‐induced bronchoconstriction in normal individuals is not mediated by thromboxane and that any increases in airway responsiveness following PAF are frequently poorly sustained, are poorly reproducible, and are not readily detectable. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:311 / 317
页数:7
相关论文
共 43 条
[21]   Effects of inhaled KP-496, a novel dual antagonist for cysteinyl Leukotrienes receptor and thromboxane A2 receptor, on allergic asthmatic responses in guinea pigs [J].
Suda, M. ;
Okuda, T. ;
Ishimura, M. ;
Kurokawa, S. ;
Tokuoka, S. ;
Nakamura, T. ;
Takahashi, Y. ;
Tanaka, H. ;
Nagai, H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :S132-S132
[22]   The Effects of Inhaled KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor and Thromboxane A2 Receptor, on Allergic Asthmatic Responses in Guinea Pigs [J].
Suda, Masahiro ;
Okuda, Toshiaki ;
Ishimura, Masakazu ;
Kurokawa, Shigeo ;
Tokuoka, Shota ;
Nakamura, Tsutomu ;
Takahashi, Yoshimasa ;
Tanaka, Hiroyuki ;
Nagai, Hiroichi .
PHARMACOLOGY, 2009, 84 (04) :249-256
[23]   MEN 16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways [J].
Valenti, Claudio ;
Cialdai, Cecilia ;
Giuliani, Sandro ;
Tramontana, Manuela ;
Quartara, Laura ;
Maggi, Carlo Alberto .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) :350-356
[24]   Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells [J].
Petri, Marcelo H. ;
Tellier, Celine ;
Michiels, Carine ;
Ellertsen, Ingvill ;
Dogne, Jean-Michel ;
Back, Magnus .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 441 (02) :393-398
[25]   EFFECTS OF SQ-27,427, A THROMBOXANE-A2 RECEPTOR ANTAGONIST, IN THE HUMAN-PLATELET AND ISOLATED SMOOTH-MUSCLE [J].
HARRIS, DN ;
GREENBERG, R ;
PHILLIPS, MB ;
MICHEL, IM ;
GOLDENBERG, HJ ;
HASLANGER, MF ;
STEINBACHER, TE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 103 (1-2) :9-18
[26]   Effects of the orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways [J].
Watanabe, M ;
Yoshihara, S ;
Abe, T ;
Oyama, M ;
Arisaka, O .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) :373-378
[27]   THE EFFECTS OF ICI-D1542, A THROMBOXANE A2 SYNTHASE INHIBITOR AND TP RECEPTOR ANTAGONIST, ON COLLAGEN-INDUCED HUMAN PLATELET DEGRANULATION AND AGGREGATION [J].
MENYS, VC .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 :P130-P130
[28]   Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562 [J].
MaassenVanDenBrink, A ;
Reekers, M ;
Bax, WA ;
Saxena, PR .
PHARMACOLOGY & TOXICOLOGY, 2000, 86 (06) :287-290
[29]   Progesterone Receptor-A and -B Have Opposite Effects on Proinflammatory Gene Expression in Human Myometrial Cells: Implications for Progesterone Actions in Human Pregnancy and Parturition [J].
Tan, Huiqing ;
Yi, Lijuan ;
Rote, Neal S. ;
Hurd, William W. ;
Mesiano, Sam .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05) :E719-E730
[30]   Characterization of human serotonin in and 1B receptors using [H-3]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist [J].
Domenech, T ;
Beleta, J ;
Palacios, JM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (03) :328-334